Jian Wang

Jian Wang

Associate, Corporate


Jian Wang’s practice focuses on cross-border mergers and acquisitions, capital markets transactions, corporate finance, investments and public company compliance matters.

Mr. Wang’s experience includes advising:

Going-Private Acquisitions

  • the special committee of the board of directors of O2Micro International Limited on the US$146 million going-private acquisition of O2Micro by FNOF Precious Honour Limited, Mr. Sterling Du and Mr. Perry Kuo
  • the independent board committee of Wanda Sports Group Company on the acquisition by Wanda Sports & Media (Hong Kong) Holding Co. Limited of the remaining 28% stake in Wanda Sports Group for US$105 million
  • New Wave Holding Limited, an entity owned by the management of Sina Corporation led by Mr. Charles Chao, on its US$2.6 billion going-private acquisition of Sina
  • a buyer group comprising of Ms. Guilan Jiang, her extended family members and Mr. Qijun Huang on their going-private acquisition of Fuling Global Inc.
  • 58.com Inc. on its US$8.7 billion going-private acquisition by an investor consortium that included Warbus Pincus Asia LLC, General Atlantic Singapore Fund Pte. Ltd., Ocean Link Partners Limited and Mr. Jinbo Yao
  • Mr. Leo Ou Chen on his US$130 million going-private acquisition of the remaining stake in Jumei International Holding Limited through a two-step merger
  • the special committee of the board of directors of Changyou.com Limited on the US$579 million going-private acquisition of Changyou.com by Sohu.com Limited
  • a buyer consortium led by Mr. Baofang Jin on its US$362 million going-private acquisition of JA Solar Holdings Co., Ltd.

Capital Markets

  • Nomura Securities International, Inc. as sole underwriter on the US$200 million IPO of Generation Asia I Acquisition Limited
  • Sinopec Group Overseas Development (2018) Limited on its multiple Rule 144A/ Regulation S offerings of U.S. dollar-denominated senior notes
  • 9F Inc. on its US$85 million IPO of American depositary shares (ADS) and listing on Nasdaq, and on its US$60 million PIPE transaction
  • Qifu Technology, Inc. on its US$200 million pre-IPO financing, US$51 million IPO of ADS and listing on Nasdaq, and its US$96 million follow-on offering of ADS by its shareholders
  • China Petroleum & Chemical Corporation on its voluntary delisting of ADS from NYSE and Rule 12h-6 deregistration under U.S. securities laws
  • CASI Pharmaceuticals, Inc. on its redomiciliation from Delaware to the Cayman Islands and the related registered exchange offering of ordinary shares
  • Huaneng Power International Inc. on its voluntary delisting of ADS from the NYSE and Rule 12h-6 deregistration under U.S. securities laws
  • U.S.-listed companies, including CASI Pharmaceuticals, Inc., China Petroleum & Chemical Corporation and 9F Inc., on ongoing regulatory compliance and preparation of filings under Securities Exchange Act of 1934, as well as Huaneng Power International Inc. and JA Solar Holdings Co., Ltd. on their regulatory compliance prior to each of their delistings



  • LL.M., New York University School of Law, 2017
  • LL.M., Xiamen University, 2015
  • LL.B., Xiamen University, 2012


  • New York


  • English
  • Chinese

Jian Wang